The 2016 Texas Neuro Conference was both interesting and empowering. The stadium was jam-packed with an audience composed of locals and those from neighboring states as well. They were looking forward to learning from experts in the field of neurology – doctors, researchers, and motivational speakers who had inspiring stories to tell about neurologic diseases, particularly Alzheimer’s disease, and breakthrough revelations and experiences from patients and families.

One of the speakers in the event spoke about the latest news on Alzheimer’s disease, which was a pertinent focus in the conference since the disease is a very common prevalence among seniors today.

Fight Against Alzheimer’s Disease

Researchers have discovered a new method to target the lethal substances that damage healthy cells in the brain. The first method was to ‘go after’ the root cause of the disease. Once this was ‘caught,’ perhaps a new drug can be formulated to treat the first sign of dementia, the hallmark of Alzheimer’s disease.

A proficient scientist by the name of Michele Vendruscolo led a study that was believed to be a ‘first in the world.’ It is called as such because according to him, this is the first time that a structured process of going after pathogens or the cause of the disease itself has been initiated. Now that the pathogens have been identified as proteins called oligomers, scientists will be able to create a strategy to formulate drugs that target these toxic substances.

Dementia is the principal cause of death in the United States, but even more, deaths are seen in the UK. Moreover, the cost of managing and treating the illness is projected to double over the next 20 years – 55 billion euros in the UK and about a trillion dollars globally every year. That is quite an astounding piece of information.


Bottom Line

Dementia and Alzheimer’s disease have been greatly affecting the world’s seniors and the families that are struggling to take care of them in spite of the physical, mental, and financial challenges Alzheimer’s disease entail. More efforts and action have been taken to find more evidence that targeting the toxic particles can eventually stop the nerve cells from dying, thus stopping the disease from further developing.